查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1433632

3D 细胞培养市场规模、份额、趋势分析报告：按技术、应用、最终用途、地区和细分市场预测，2024-2030 年

3D Cell Culture Market Size, Share & Trends Analysis Report By Technology (Scaffold Based, Scaffold Free, Bioreactors, Microfluidics, Bioprinting), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10个工作天内

价格

3D 细胞培养市场成长与趋势：

根据Grand View Research, Inc.最新报告显示，到2030年，全球3D细胞培养市场规模预计将达到32.1亿美元，2024年至2030年复合年增长率预计将达到11.22%。

该市场是由体外测试模型的技术进步、对个人化医疗的日益关注以及政府对研发的支援法律所推动的。此外，慢性病盛行率的不断上升以及细胞疗法在治疗中的重要性日益增加，正在为产业扩张创造动力。

组织工程在创建 3D 培养模型方面取得了重大进展，该模型比传统的 2D 细胞培养更准确地模拟体内培养基。因此，3D 细胞培养系统在毒性测试、药物发现和再生医学开发中的使用增加。此外，行业参与者最近推出的产品也显着促进了市场成长。例如，2023 年 6 月，Pixelgen Technologies 推出了首款分子像素化套件，用于细胞表面蛋白质的 3D 空间研究。

此外，微流体、生物列印和高内涵筛检系统等先进技术的发展正在利用这些模型的功能。这些技术可以更好地控制培养条件、细胞组织以及执行高效筛检的能力，从而促进了 3D 培养系统的使用。此外，市场相关人员之间加强合作，利用生物列印和微流体技术来开发培养模型，正在推动市场成长。例如，AIM Biotech和MatTek于2023年6月合作，提供创新的idenTX和organiX微流体3D组织培养平台，作为神经生物学、免疫肿瘤学和血管生物学特定领域的完整药物发现研究服务。

3D培养可以忠实地再现器官的典型微观结​​构和型态，因此不断用于需要体内模型来分析药物对身体组织和器官影响的研究，并且正在开发中。这一因素，再加上各种体外应用的支架材料和结构方面的多种选择，预计将推动支架收益。最近的研究探讨了各种支架的使用，包括石墨烯支架、奈米纤维、天然海洋胶原蛋白和冷冻铸造。此外，诸如实验室晶片等技术在多种类型分析中的新兴应用，如增殖、刺激、活力、运输、高内涵筛检、膜片钳、代谢活性等，正在推动对先进、高效的解决方案，预计将导致

然而，3D 细胞模型产品缺乏一致性是预期阻碍市场成长的主要缺点之一。此外，细胞培养差异、标准化挑战、规模和製造问题以及品管问题等各种因素可能会阻碍市场成长。

3D 细胞培养市场报告亮点

  • 2023年，基于支架的技术领域以48.94%的收益占有率主导市场，这归因于基于支架的培养在组织工程和再生医学应用中的应用不断增加。
  • 2023年，干细胞研究和组织工程占最大。另一方面，由于癌症盛行率的上升以及 3D 细胞培养在癌症研究中提供的优势，预计癌症研究领域将出现最快的成长。
  • 在最终用途领域，生物技术和製药公司按 2023 年收益占有率占据市场主导地位。收益的高成长归因于生物製药的持续成长和商业性成功以及大型製药公司投资组合的扩张。
  • 北美地区在2023年以38.97%的收益占有率主导全球市场。这是由于先进的医疗基础设施、新兴经济体、主要参与者以及它们采取的各种策略性倡议的存在。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19感染疾病的影响分析

第四章技术商业分析

  • 3D细胞培养市场：技术变化分析
  • 鹰架底座
  • 无鹰架
  • 反应器
  • 微流体
  • 生物列印

第 5 章应用程式的商业分析

  • 3D细胞培养市场：应用变化分析
  • 癌症研究
  • 干细胞研究/组织工程
  • 药物开发/毒性测试
  • 其他的

第 6 章最终用途业务分析

  • 3D 细胞培养市场：最终用途变异分析
  • 生技/製药公司
  • 学术/研究机构
  • 医院
  • 其他的

第七章 区域业务分析

  • 3D 细胞培养份额：按地区划分，2023 年和 2030 年
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第八章 竞争形势

  • 公司分类
  • 策略规划
  • 2023 年企业市场分析
  • 公司简介/名单
    • Thermo Fisher Scientific, Inc
    • Merck KGaA
    • PromoCell GmbH
    • Lonza
    • Corning Incorporated
    • Avantor, Inc.
    • Tecan Trading AG
    • REPROCELL Inc.
    • CN Bio Innovations Ltd.
    • Lena Biosciences
Product Code: GVR-1-68038-091-0

3D Cell Culture Market Growth & Trends:

The global 3D cell culture market size is anticipated to reach USD 3.21 billion by 2030 and is anticipated to expand at a CAGR of 11.22% during 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by technological advancements in in-vitro testing models, a rising focus on personalized medicine, and supportive government legislation for R&D. Moreover, the increasing prevalence of chronic disorders, and the growing significance of cell therapies in their treatment have created momentum for industry expansion.

Tissue engineering has made significant developments in creating 3D culture models that mimic the in-vivo culture media more precisely than the conventional 2D cell cultures. This resulted in increased utilization of 3D cell culture systems for toxicity testing, drug discovery, and regenerative medicine development. Also, recent product launches from industry players have supported market growth to a significant extent. For instance, in June 2023, Pixelgen Technologies launched its first molecular pixelation kit for 3D spatial study of proteins present on cell surface.

In addition, the development of advanced technologies like microfluidics, bioprinting, and high-content screening systems, has leveraged the capabilities of these models. These technologies allow excellent control over culture conditions, cell organization, and the capability to perform high-efficiency screening, thereby fueling the utilization of 3D culture systems. Moreover, increased collaboration between market players to utilize bioprinting and microfluidics techniques in developing culture models has propelled market growth. For instance, in June 2023, AIM Biotech and MatTek partnered together to offer innovative idenTX and organiX microfluidic 3D tissue culture platforms along with complete drug discovery research services in specific areas of neurobiology, immune-oncology, and vascular biology.

3D cultures can closely replicate the typical microarchitecture and morphology of organs and hence are continuously developed for studies that require in vivo models to analyze the effect of a drug over body tissues and organs. This factor, coupled with the availability of several choices in terms of the material and structure of the scaffold for a variety of in-vitro applications, is anticipated to boost revenue generation for scaffolds. Recent research has explored the use of a broad range of scaffolds, such as graphene scaffolds, nanofibers, natural marine collagen, freeze-casting, and others. In addition, emerging applications of techniques such as lab-on-a-chip in several assay types, including proliferation, stimulation, viability, transport, high content screening, patch clamping, and metabolic activity are anticipated to lead to an increase in demand for advanced and efficient solutions.

However, the lack of consistency in 3D cell model products is one of the major drawbacks that is expected to hinder the growth of the market. Moreover, various factors such as variability in cell culture, standardized challenges, scale & manufacturing issues, and quality control issues might hamper the market growth.

3D Cell Culture Market Report Highlights:

  • The scaffold-based technology segment dominated the market in 2023 with a revenue share of 48.94% and is attributed to the increasing application of scaffold-based cultures in tissue engineering and regenerative medicine applications
  • Stem cell research & tissue engineering held the largest share in 2023, whereas the cancer institute segment is expected to witness the fastest growth owing to the rising prevalence of cancer, and the benefits offered by 3D cell cultures in cancer research
  • In the end-use segment, biotechnology and pharmaceutical companies dominated the market with a revenue share in 2023. The higher revenue growth is attributed to the continuous growth and commercial success of biopharmaceuticals coupled with the expanding portfolio of the major pharmaceutical companies
  • North America region dominated the global market in 2023 with a revenue share of 38.97%, owing to the presence of advanced healthcare infrastructure, developed economies, the presence of key players, and various strategic initiatives undertaken by them

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Technology Segment
    • 1.1.2. Application Segment
    • 1.1.3. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information or Data Analysis:
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Validation
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing demand for organ transplantation & tissue engineering
      • 3.2.1.2. Technological advancements in scaffold free technology
      • 3.2.1.3. Rise in investments and R&D funding for cell-based research
      • 3.2.1.4. Increasing focus on developing alternative to animal testing
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost associated with implementation
      • 3.2.2.2. Lack of compatibility and consistency
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Technology Business Analysis

  • 4.1. 3D Cell Culture Market: Technology Movement Analysis
  • 4.2. Scaffold Based
    • 4.2.1. Scaffold based market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.2. Hydrogels
      • 4.2.2.1. Hydrogels market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.3. Polymeric Scaffolds
      • 4.2.3.1. Polymeric scaffolds market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.4. Micropatterned Surface Microplates
      • 4.2.4.1. Micropatterned surface microplates market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.5. Nanofiber Based Scaffolds
      • 4.2.5.1. Nanofiber based scaffolds market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.3. Scaffold Free
    • 4.3.1. Scaffold free market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Hanging Drop Microplates
      • 4.3.2.1. Hanging drop microplates market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Spheroid Microplates with ULA coating
      • 4.3.3.1. Spheroid microplates with ULA coating market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Magnetic Levitation
      • 4.3.4.1. Magnetic levitation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4. Bioreactors
    • 4.4.1. Bioreactors market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Microfluidics
    • 4.5.1. Microfluidics market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6. Bioprinting
    • 4.6.1. Bioprinting market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. 3D Cell Culture Market: Application Movement Analysis
  • 5.2. Cancer Research
    • 5.2.1. Cancer research market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.3. Stem Cell Research & Tissue Engineering
    • 5.3.1. Stem cell research & tissue engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4. Drug Development & Toxicity Testing
    • 5.4.1. Drug development & toxicity testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. End-Use Business Analysis

  • 6.1. 3D Cell Culture Market: End-Use Movement Analysis
  • 6.2. Biotechnology & Pharmaceutical Companies
    • 6.2.1. Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.3. Academic & Research Institutes
    • 6.3.1. Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. 3D Cell Culture Share By Region, 2023 & 2030
  • 7.2. North America
    • 7.2.1. North America 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Target Disease Prevalence
      • 7.2.2.4. U.S. 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Target Disease Prevalence
      • 7.2.3.4. Canada 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Target Disease Prevalence
      • 7.3.2.4. UK 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Target Disease Prevalence
      • 7.3.3.4. Germany 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Target Disease Prevalence
      • 7.3.4.4. France 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Target Disease Prevalence
      • 7.3.5.4. Italy 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Target Disease Prevalence
      • 7.3.6.4. Spain 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Target Disease Prevalence
      • 7.3.7.4. Denmark 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Target Disease Prevalence
      • 7.3.8.4. Sweden 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Target Disease Prevalence
      • 7.3.9.4. Norway 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Target Disease Prevalence
      • 7.4.2.4. Japan 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Target Disease Prevalence
      • 7.4.3.4. China 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Target Disease Prevalence
      • 7.4.4.4. India 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Target Disease Prevalence
      • 7.4.5.4. Australia 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Target Disease Prevalence
      • 7.4.6.4. Thailand 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Target Disease Prevalence
      • 7.4.7.4. South Korea 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Target Disease Prevalence
      • 7.5.2.4. Brazil 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Target Disease Prevalence
      • 7.5.3.4. Mexico 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Target Disease Prevalence
      • 7.5.4.4. Argentina 3D Cell Culture, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Target Disease Prevalence
      • 7.6.2.4. South Africa 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Target Disease Prevalence
      • 7.6.3.4. Saudi Arabia 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Target Disease Prevalence
      • 7.6.4.4. UAE 3D Cell Culture, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Target Disease Prevalence
      • 7.6.5.4. Kuwait 3D Cell Culture, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific, Inc
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. PromoCell GmbH
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Lonza
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Corning Incorporated
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Avantor, Inc.
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Tecan Trading AG
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. REPROCELL Inc.
      • 8.4.8.1. Overview
      • 8.4.8.2. Product Benchmarking
      • 8.4.8.3. Strategic Initiatives
    • 8.4.9. CN Bio Innovations Ltd.
      • 8.4.9.1. Overview
      • 8.4.9.2. Product Benchmarking
      • 8.4.9.3. Strategic Initiatives
    • 8.4.10. Lena Biosciences
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global 3D cell culture market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America 3D cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 5 North America 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 U.S. 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 8 U.S. 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 Canada 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Canada 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 12 Canada 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Europe 3D cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 14 Europe 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 15 Europe 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 16 Europe 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 Germany 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Germany 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 19 Germany 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 UK 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 21 UK 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 22 UK 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 France 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 24 France 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 25 France 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Italy 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Italy 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 28 Italy 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Spain 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Spain 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 31 Spain 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Denmark 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Denmark 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 34 Denmark 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Sweden 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Sweden 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 37 Sweden 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 Norway 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Norway 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 40 Norway 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific 3D cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 China 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 46 China 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 47 China 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Japan 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Japan 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 50 Japan 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 India 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 52 India 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 53 India 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 South Korea 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 55 South Korea 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 56 South Korea 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Australia 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Australia 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 59 Australia 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Thailand 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Thailand 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 62 Thailand 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Latin America 3D cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 64 Latin America 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 65 Latin America 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 66 Latin America 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 67 Brazil 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Brazil 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 69 Brazil 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 Mexico 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 71 Mexico 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 72 Mexico 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 73 Argentina 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Argentina 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 75 Argentina 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 76 MEA 3D cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 77 MEA 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 78 MEA 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 79 MEA 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 80 South Africa 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 81 South Africa 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 82 South Africa 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 UAE 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 87 UAE 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 88 UAE 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
  • Table 89 Kuwait 3D cell culture market, by technology, 2018 - 2030 (USD Million)
  • Table 90 Kuwait 3D cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 91 Kuwait 3D cell culture market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 3D cell culture market: market outlook
  • Fig. 9 Parent market outlook
  • Fig. 10 3D cell culture market driver impact
  • Fig. 11 3D cell culture market restraint impact
  • Fig. 12 3D cell culture market: technology outlook and key takeaways
  • Fig. 13 3D cell culture market: technology movement analysis
  • Fig. 14 Scaffold based market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Hydrogels market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Polymeric scaffolds market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Micropatterned surface microplates market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Nanofiber based scaffolds market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Scaffold free market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Hanging drop microplates market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Spheroid microplates with ULA coating market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Magnetic levitation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Bioreactors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Bioprinting market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 3D cell culture market: application outlook and key takeaways
  • Fig. 27 3D cell culture market: application movement analysis
  • Fig. 28 Cancer research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Stem cell research & tissue engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Drug development & toxicity testing market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 3D cell culture market: end-use outlook and key takeaways
  • Fig. 33 3D cell culture market: end-use movement analysis
  • Fig. 34 Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Hospitals market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 37 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 North America 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Canada 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Europe 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 UK 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Germany 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 France 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Italy 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Spain 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Denmark 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Sweden 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Norway 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 China 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Japan 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 India 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Thailand 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 South Korea 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Australia 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Brazil 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Mexico 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Middle East and Africa 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 South Africa 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Saudi Arabia 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 UAE 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Kuwait 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)